PAK3 - p21 (RAC1) activated kinase 3 Gene
Species: Sus scrofa
Gene Type: protein coding
Gene ID: 100624533
About PAK3
Primary_assembly X: 90,942,077-91,238,565 forward strand.Sscrofa11.1:CM000830.5
This gene has 7 transcripts (splice variants), 213 orthologues and 36 paralogues. Broad expression in mixtures (RPKM 1.9), ovary (RPKM 1.8) and 8 other tissues.
PAK3 Products (16)
| mRNA | Protein | Name |
|---|---|---|
| XM_021080683.1 | XP_020936342.1 | serine/threonine-protein kinase PAK 3 isoform X1 |
| XM_021080684.1 | XP_020936343.1 | serine/threonine-protein kinase PAK 3 isoform X2 |
| XM_021080690.1 | XP_020936349.1 | serine/threonine-protein kinase PAK 3 isoform X3 |
| XM_021080676.1 | XP_020936335.1 | serine/threonine-protein kinase PAK 3 isoform X1 |
| XM_021080680.1 | XP_020936339.1 | serine/threonine-protein kinase PAK 3 isoform X1 |
| XM_021080685.1 | XP_020936344.1 | serine/threonine-protein kinase PAK 3 isoform X2 |
| XM_021080681.1 | XP_020936340.1 | serine/threonine-protein kinase PAK 3 isoform X1 |
| XM_021080686.1 | XP_020936345.1 | serine/threonine-protein kinase PAK 3 isoform X2 |
| XM_021080675.1 | XP_020936334.1 | serine/threonine-protein kinase PAK 3 isoform X1 |
| XM_021080687.1 | XP_020936346.1 | serine/threonine-protein kinase PAK 3 isoform X2 |
| XM_021080677.1 | XP_020936336.1 | serine/threonine-protein kinase PAK 3 isoform X1 |
| XM_021080679.1 | XP_020936338.1 | serine/threonine-protein kinase PAK 3 isoform X1 |
| XM_021080682.1 | XP_020936341.1 | serine/threonine-protein kinase PAK 3 isoform X1 |
| XM_021080688.1 | XP_020936347.1 | serine/threonine-protein kinase PAK 3 isoform X2 |
| XM_021080678.1 | XP_020936337.1 | serine/threonine-protein kinase PAK 3 isoform X1 |
| XM_021080689.1 | XP_020936348.1 | serine/threonine-protein kinase PAK 3 isoform X2 |
PAK3 Protein Structure
PBD
PBD: pfam00786 (68 - 161)
STKc_PAK3
STKc_PAK3: cd06656 (283 - 579)
- 0
- 100
- 200
- 300
- 400
- 500
- 580 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
serine/threonine-protein kinase PAK 3 |
|
Related Agents
- Clinical Phase
- Pre-clinical Phase
Clinical Phase
Bioactive Molecules
(3)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-13007 | PF-3758309 | Inhibitor | 99.79% | Phase 1 |
| HY-13007B | PF-3758309 dihydrochloride | Inhibitor | / | Phase 1 |
| HY-13007A | PF-3758309 hydrochloride | Inhibitor | / | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(6)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-15542A | FRAX597 | Inhibitor | 99.36% | Unkown |
| HY-15542B | FRAX486 | Inhibitor | 98.10% | Unkown |
| HY-123739 | LDN-0028574 | Inhibitor | / | Unkown |
| HY-146786 | ZMF-10 | Inhibitor | / | Unkown |
| HY-178812 | PI3Kα-IN-27 | Inhibitor | / | Unkown |
| HY-118606 | LDN-0044878 | Inhibitor | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service